Abi-1 is a key adaptor protein that is involved in various signaling pathways, including those governed by growth factors, kinase activities, and cytoskeletal dynamics. The chemicals listed interact with these pathways, ultimately influencing the state and activity of Abi-1. For instance, growth factors like EGF and PDGF bind to their respective receptors, initiating a cascade of phosphorylation events that can lead to the activation of Abi-1 as part of the signaling complex. In contrast, compounds such as Genistein and Dasatinib act as kinase inhibitors, influencing the phosphorylation status of proteins that are upstream or within the same pathway as Abi-1, thus modulating its activity indirectly. Similarly, inhibitors of specific kinases such as PI3K, MEK, JNK, and p38 MAPK (LY294002, U0126, SP600125, and SB203580, respectively) can suppress or alter the signaling routes that converge on or pass through Abi-1, affecting its activation state.
On a cellular level, the actin and microtubule cytoskeleton play a significant role in the regulation of Abi-1. Chemicals like Nocodazole and Cytochalasin D, which disrupt microtubule and actin filaments, respectively, can impact the spatial distribution and association of Abi-1 with other signaling components, thus influencing its activity. Collectively, these chemicals do not directly activate Abi-1 but engage in modulating the complex network of signaling events that control Abi-1's functional state within the cell. This modulation can result in changes in the activity of Abi-1, either enhancing or diminishing its role in the relevant signaling pathways. These compounds cover a wide range of chemical classes and mechanisms of action, but their collective influence on the pathways involving Abi-1 categorizes them as indirect activators of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that can modulate Abi-1 activity by affecting its phosphorylation state. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src family kinase inhibitor, can alter Abi-1 activity through non-receptor tyrosine kinase pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Another Src family kinase inhibitor that can modify Abi-1 activity indirectly through similar pathways as Dasatinib. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can affect Abi-1 activity by altering PI3K/Akt signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, can alter Abi-1 activity through the p38 MAPK pathway. | ||||||